A Q&A With A Biotech Founder/Entrepreneur
Source: Life Science Leader
By Dan Schell, Chief Editor, Clinical Leader
While an Entrepreneur in Residence at Atlas Venture, Nello Mainolfi, Ph.D., helped cofound Kymera Therapeutics, a Boston-based clinical-stage biopharmaceutical company focused on targeted protein degradation, a new approach to addressing previously intractable disease targets. Prior to Atlas, he used his training as a chemist to work seven years at the Novartis Institutes for Biomedical Research, where he helped identify more than 10 compounds that have entered preclinical and clinical development.
access the Magazine Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.
Subscribe to Life Science Leader
X
Subscribe to Life Science Leader
This website uses cookies to ensure you get the best experience on our website. Learn more